Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

Adv Pharm Bull. 2024;14(1): 48-66. doi: 10.34172/apb.2024.016

PMID: 38585451 PMCID: PMC10997935

Review Article

Lipid-Based Nanoparticles as Oral Drug Delivery Systems: Overcoming Poor Gastrointestinal Absorption and Enhancing Bioavailability of Peptide and Protein Therapeutics

Soheil Mehrdadi ¹ *

Cited by CrossRef: 2

1- SAHOO U, SAHOO P, SAHOO V, SAHOO J. NANOTECHNOLOGY-DRIVEN INNOVATIONS IN HYPERTENSION MANAGEMENT: FORMULATION STRATEGIES, CHALLENGES, AND FUTURE DIRECTIONS. Asian J Pharm Clin Res. 2025;:58 [Crossref]

2- Veider F, To D, Saleh A, Laffleur F, Kali G, Hense D, Strube O, Bernkop-Schnürch A. Charge-converting nanocarriers: Phosphorylated polysaccharide coatings for overcoming intestinal barriers. International Journal of Biological Macromolecules. 2024;281:136308 [Crossref]

3- Gisela Bevilacqua Rolfsen F, Guedmiller Souza D, Ariana D, Livia Rodrigues F, Eryvaldo Socrates Tabosa D, Fábio D, Anselmo Gomes D. Dimethyl Fumarate Sterically Stabilized Solid Lipid Nanoparticles. Physicochemical properties and in vitro drug release. Int J Nanomater Nanotechnol Nanomed. 2025;11(1):015 [Crossref]